Jon Stranan, a master's student in the Nanomedicine Lab, has successfully defended his thesis on cell-based therapies for Alzheimer's Disease.
Jon Stranan, a master's student in the Gallego-Perez Nanomedicine Lab, successfully defended his thesis on Monday, April 11, which is titled "Assessing Functional Outcomes in Murine Models of Alzheimer’s Disease Following Implementation of an Engineered Cell-based Therapy". Jon's thesis focused on using DNA molecules to reprogram fibroblasts into endothelial cells or neurons that can correct the two main dysfunctions of Alzheimer's disease: loss of vascularity and loss of neurons. He was a member of the Gallego-Perez Lab from 2021 to 2022. Following graduation, Jon has accepted a position as a graduate research associate in the Gallego-Perez Nanomedicine Lab, where he will pursue his PhD in the Department of Biomedical Engineering. Congratulations to Jon!